Treatment with rilpivirine does not alter plasma concentrations of the CYP3A substrates tadalafil and midazolam in humans.
暂无分享,去创建一个
W. Haefeli | G. Mikus | J. Burhenne | S. Schnaidt | N. Hohmann | A. Carls | Lukas Witt | Raphael Reinhard
[1] J. Gillespie,et al. Effect of Tadalafil on Cytochrome P450 3A4–mediated Clearance: Studies in Vitro and in Vivo , 2005, Clinical pharmacology and therapeutics.
[2] L Zhang,et al. A regulatory viewpoint on transporter-based drug interactions. , 2008, Xenobiotica; the fate of foreign compounds in biological systems.
[3] W. Haefeli,et al. Effect of Simultaneous Induction and Inhibition of CYP3A by St John's Wort and Ritonavir on CYP3A Activity , 2010, Clinical pharmacology and therapeutics.
[4] W. Haefeli,et al. Determining the Time Course of CYP3A Inhibition by Potent Reversible and Irreversible CYP3A Inhibitors Using A Limited Sampling Strategy , 2011, Clinical pharmacology and therapeutics.
[5] K. Hillgren,et al. Efflux Transport Is an Important Determinant of Ethinylestradiol Glucuronide and Ethinylestradiol Sulfate Pharmacokinetics , 2011, Drug Metabolism and Disposition.
[6] C Gibson,et al. Rifampin's Acute Inhibitory and Chronic Inductive Drug Interactions: Experimental and Model‐Based Approaches to Drug–Drug Interaction Trial Design , 2011, Clinical pharmacology and therapeutics.
[7] W. Haefeli,et al. Drug Interaction of Efavirenz and Midazolam: Efavirenz Activates the CYP3A-Mediated Midazolam 1′-Hydroxylation In Vitro , 2012, Drug Metabolism and Disposition.
[8] Gerd Mikus,et al. Quantification of femtomolar concentrations of the CYP3A substrate midazolam and its main metabolite 1′-hydroxymidazolam in human plasma using ultra performance liquid chromatography coupled to tandem mass spectrometry , 2012, Analytical and Bioanalytical Chemistry.
[9] A. Lau,et al. Agonism of human pregnane X receptor by rilpivirine and etravirine: comparison with first generation non-nucleoside reverse transcriptase inhibitors. , 2013, Biochemical pharmacology.
[10] W. Haefeli,et al. Influence of sildenafil and tadalafil on the enzyme- and transporter-inducing effects of bosentan and ambrisentan in LS180 cells. , 2013, Biochemical pharmacology.
[11] H. Crauwels,et al. Clinical perspective on drug-drug interactions with the non-nucleoside reverse transcriptase inhibitor rilpivirine. , 2013, AIDS reviews.
[12] R. Palacios,et al. Prevalence and factors associated with erectile dysfunction in a cohort of HIV-infected patients , 2013 .
[13] L. Bertilsson,et al. Pharmacogenetic and pharmacokinetic aspects of CYP3A induction by efavirenz in HIV patients , 2012, The Pharmacogenomics Journal.
[14] Suman Sen,et al. Time‐Dependent Inhibition and Induction of Human Cytochrome P4503A4/5 by an Oral IAP Antagonist, LCL161, In Vitro and In Vivo in Healthy Subjects , 2013, Journal of clinical pharmacology.
[15] C. Sabin. Do people with HIV infection have a normal life expectancy in the era of combination antiretroviral therapy? , 2013, BMC Medicine.
[16] W. Haefeli,et al. Potential of the novel antiretroviral drug rilpivirine to modulate the expression and function of drug transporters and drug-metabolising enzymes in vitro. , 2013, International journal of antimicrobial agents.
[17] W E Haefeli,et al. A Nanogram Dose of the CYP3A Probe Substrate Midazolam to Evaluate Drug Interactions , 2013, Clinical pharmacology and therapeutics.
[18] H. Crauwels,et al. Lack of an effect of rilpivirine on the pharmacokinetics of ethinylestradiol and norethindrone in healthy volunteers. , 2014, International journal of clinical pharmacology and therapeutics.
[19] H. Crauwels,et al. The effect of rilpivirine on the pharmacokinetics of methadone in HIV‐negative volunteers , 2014, Journal of clinical pharmacology.
[20] V. Valcour,et al. Polypharmacy, Drug–Drug Interactions, and Potentially Inappropriate Medications in Older Adults with Human Immunodeficiency Virus Infection , 2014, Journal of the American Geriatrics Society.
[21] W. Haefeli,et al. Dried Blood Spot Technique for the Monitoring of Ambrisentan, Bosentan, Sildenafil, and Tadalafil in Patients with Pulmonary Arterial Hypertension. , 2015, Analytical chemistry.
[22] E. Kharasch,et al. Influence of HIV antiretrovirals on methadone N-demethylation and transport. , 2015, Biochemical pharmacology.